CYCCP

Cyclacel Pharmaceuticals Inc.

Price

return (12m)

0.00%

p/e

-8.63

p/bv

3.14

DIVIDEND YIELD

33.29%

CYCCP price

Cyclacel Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment CYCCP

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals CYCCP

Valuation

P/E

-8.63

Sector -4.03

Industry -4.03

P/BV

3.14

Sector 2.05

Industry 2.05

P/Revenue (PSR)

Sector -4.26

Industry -4.26

EV/EBITDA

-5.39

Sector -238.32

Industry -238.32

EV/EBIT

-5.39

Sector -670.55

Industry -670.55

P/EBITDA

-8.63

Sector -4.23

Industry -4.23

P/EBIT

-8.63

Sector -4.29

Industry -4.29

P/Total Assets

2.59

Sector 1.45

Industry 1.45

P/Ativo Circ. Liq.

Sector -11.51

Industry -11.51

P/Cap.Giro

Sector -11.45

Industry -11.45

EPS

-0.84

Sector -2.20

Industry -2.20

BVPS

2.30

Sector 1.95

Industry 1.95

Efficiency

Gross Margin

0.00%

Sector 36.28%

Industry 36.28%

EBITDA Margin

Sector -16,822.56%

Industry -16,822.56%

EBIT Margin

Sector -4,238,732.42%

Industry -4,238,732.42%

Operating Margin

0.00%

Sector -38.78%

Industry -38.78%

Net Profit Margins

0.00%

Sector -39.92%

Industry -39.92%

Giro Ativos

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-36.36%

Sector -65.93%

Industry -65.93%

ROA

-30.00%

Sector -66.10%

Industry -66.10%

ROIC

Sector -2,918.81%

Industry -2,918.81%

Dividends

Dividend yield

33.29%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

Sector 2.91

Industry 2.91

Dívida Líquida/EBITDA

3.24

Sector -13,526,126.12

Industry -13,526,126.12

Dívida Líquida/EBIT

3.24

Sector -3.66

Industry -3.66

Dívida Líquida/Patrimônio

-1.18

Sector -1.10

Industry -1.10

Dívida Bruta/Patrimônio

0.00

Sector -0.10

Industry -0.10

Equity/Assets

0.83

Sector 0.42

Industry 0.42

Liabilities/Assets

0.18

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals CYCCP

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
CYCCP	-8.63	3.14	-36.36%	33.29%	$11.39 M	0.00%
JNJ	30.06	7.44	24.76%	1.99%	$632.34 B	21.48%
PFE	18.39	1.52	8.29%	7.11%	$137.74 B	11.83%
ABBV	126.05	-69.30	-54.98%	2.60%	$458.19 B	5.79%
NVO	11.48	6.93	60.40%	3.79%	$217.68 B	37.15%
MRK	36.33	7.07	19.45%	2.56%	$324.61 B	13.59%
AZN	25.14	5.51	21.93%	1.90%	$261.15 B	17.19%
GILD	17.54	6.90	39.33%	2.47%	$161.64 B	30.99%
BMY	17.28	6.25	36.19%	4.05%	$125.69 B	15.01%
ZTS	11.99	9.80	81.75%	2.74%	$31.69 B	27.79%
REGN	15.66	2.20	14.08%	0.55%	$69.27 B	29.65%
HALO	27.62	43.86	158.82%	0.00%	$9.63 B	23.13%
AMGN	26.05	22.11	84.87%	2.60%	$203.18 B	20.96%
MCK	21.59	-123.30	-570.98%	0.39%	$102.83 B	1.18%
VRTX	28.04	6.28	22.41%	0.00%	$121.66 B	35.51%
CAH	34.58	-20.13	-58.20%	0.89%	$53.78 B	0.62%
HRMY	14.10	2.26	16.00%	0.00%	$2.05 B	16.20%
BIIB	21.68	1.59	7.36%	0.00%	$29.75 B	13.81%
MEDP	34.42	38.99	113.29%	0.00%	$16.92 B	17.67%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

CYCCP Historical Dividends

current DY: 33.29%

5-year average DY: 794.07%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	10/17/2025	11/01/2025	0.15000000
Dividends	07/18/2025	08/01/2025	0.15000000
Dividends	04/28/2025	05/01/2025	2.25000000
Dividends	01/18/2024	02/01/2024	2.25000000
Dividends	10/18/2023	11/01/2023	2.25000000
Dividends	07/19/2023	08/01/2023	2.25000000
Dividends	04/19/2023	05/01/2023	2.25000000
Dividends	01/11/2023	02/01/2023	2.25000000
Dividends	10/12/2022	11/01/2022	2.25000000
Dividends	07/13/2022	08/01/2022	2.25000000
Dividends	04/12/2022	05/01/2022	2.25000000
Dividends	01/12/2022	02/01/2022	2.25000000
Dividends	10/13/2021	11/01/2021	2.25000000
Dividends	07/14/2021	08/01/2021	2.25000000
Dividends	04/14/2021	05/01/2021	2.25000000
Dividends	01/13/2021	02/01/2021	2.25000000
Dividends	10/14/2020	11/01/2020	2.25000000
Dividends	07/15/2020	08/01/2020	2.25000000
Dividends	04/13/2020	05/01/2020	2.25000000
Dividends	01/15/2020	02/01/2020	2.25000000
Dividends	10/10/2019	11/01/2019	2.25000000
Dividends	07/10/2019	08/01/2019	2.25000000
Dividends	04/11/2019	05/01/2019	2.25000000
Dividends	01/10/2019	02/01/2019	2.25000000
Dividends	10/11/2018	11/01/2018	2.25000000
Dividends	07/11/2018	08/01/2018	2.25000000
Dividends	04/09/2018	05/01/2018	2.25000000
Dividends	01/10/2018	02/01/2018	2.25000000
Dividends	10/11/2017	11/01/2017	2.25000000
Dividends	07/12/2017	08/01/2017	2.25000000
Dividends	04/12/2017	05/01/2017	2.25000000
Dividends	01/16/2017	02/01/2017	2.25000000
Dividends	10/13/2016	11/01/2016	2.25000000
Dividends	07/13/2016	08/01/2016	2.25000000
Dividends	04/14/2016	05/01/2016	2.25000000
Dividends	01/19/2016	02/01/2016	2.25000000
Dividends	10/21/2015	11/02/2015	2.25000000
Dividends	07/15/2015	08/03/2015	2.25000000
Dividends	04/15/2015	05/01/2015	2.25000000
Dividends	01/01/2015	02/02/2015	2.25000000
Dividends	09/29/2014	11/01/2014	2.25000000
Dividends	06/27/2014	08/01/2014	2.25000000
Dividends	04/16/2014	05/01/2014	2.25000000
Dividends	01/15/2014	02/03/2014	2.25000000
Dividends	10/17/2013	11/01/2013	2.25000000
Dividends	07/18/2013	08/01/2013	2.25000000
Dividends	04/17/2013	05/01/2013	2.25000000
Dividends	01/18/2013	02/01/2013	2.25000000
Dividends	04/20/2011	05/02/2011	2.25000000
Dividends	01/19/2011	02/01/2011	2.25000000
Dividends	01/15/2009	01/30/2009	2.25000000
Dividends	10/16/2008	11/01/2008	2.25000000
Dividends	07/16/2008	08/01/2008	2.25000000
Dividends	04/16/2008	05/01/2008	2.25000000
Dividends	01/16/2008	02/01/2008	2.25000000
Dividends	10/17/2007	11/01/2007	2.25000000
Dividends	07/18/2007	08/01/2007	2.25000000
Dividends	04/18/2007	05/01/2007	2.25000000
Dividends	01/18/2007	02/01/2007	2.25000000
Dividends	10/19/2006	11/01/2006	2.25000000
Dividends	07/20/2006	08/01/2006	2.25000000
Dividends	04/27/2006	05/01/2006	2.25000000
Dividends	01/18/2006	02/01/2006	2.25000000
Dividends	10/19/2005	11/01/2005	2.25000000
Dividends	07/20/2005	08/01/2005	2.25000000
Dividends	04/20/2005	05/02/2005	2.25000000
Dividends	01/19/2005	02/01/2005	2.19600000

ABOUT Cyclacel Pharmaceuticals

Cyclacel Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (1 people)

United States

29 years

Founded: 1997

2006

Time since IPO - 20 years

12

Employees

Cyclacel Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $11.39 million, with shareholders equity totaling $3.63 million.

The company employs approximately 12 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Cyclacel Pharmaceuticals Inc. reported $- in revenue, generating net income of $-1.32 million.

Key financial metrics include a P/E ratio of -8.63, a price-to-book (P/B) ratio of 3.14, and a trailing twelve-month dividend yield of 33.29%.

The company trades under the ticker CYCCP.

Market cap

$11.39 million

Net worth

$3.63 million

$3,630,000.00

Assets

$4.40 million

$4,400,000.00

Total Shares Outstanding

1.58 million

1,580,000

Average Daily Trading Volume

$7.05 Thousand

$7,052.44

Sector

Health Care

Industry

Biotechnology

CYCCP

CYCCP revenue and profits

Financial Results CYCCP

DRAG THE FRAME TO SEE MORE DATA

CYCCP cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$840.90 18,75% (12M)

P/E

21.59

0.39%

ROE

-570.98%

P/BV

-123.30

CAH - Cardinal Health

$228.03 46,64% (12M)

P/E

34.58

0.89%

ROE

-58.20%

P/BV

-20.13

JNJ - Johnson & Johnson

$263.40 61,26% (12M)

P/E

30.06

1.99%

ROE

24.76%

P/BV

7.44

MRK - Merck & Co.

$131.07 59,86% (12M)

P/E

36.33

2.56%

ROE

19.45%

P/BV

7.07

AZN - AstraZeneca

$169.26 19,89% (12M)

P/E

25.14

1.90%

ROE

21.93%

P/BV

5.51

ABBV - AbbVie

$259.36 41,86% (12M)

P/E

126.05

2.60%

ROE

-54.98%

P/BV

-69.30

NVO - Novo Nordisk

$48.77 --25,90% (12M)

P/E

11.48

3.79%

ROE

60.40%

P/BV

6.93

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$840.90 18,75% (12 M)

P/L

21.59

0.39%

ROE

-570.98%

P/VP

-123.30

CAH - Cardinal Health

$228.03 46,64% (12 M)

P/L

34.58

0.89%

ROE

-58.20%

P/VP

-20.13

JNJ - Johnson & Johnson

$263.40 61,26% (12 M)

P/L

30.06

1.99%

ROE

24.76%

P/VP

7.44

MRK - Merck & Co.

$131.07 59,86% (12 M)

P/L

36.33

2.56%

ROE

19.45%

P/VP

7.07

AZN - AstraZeneca

$169.26 19,89% (12 M)

P/L

25.14

1.90%

ROE

21.93%

P/VP

5.51

ABBV - AbbVie

$259.36 41,86% (12 M)

P/L

126.05

2.60%

ROE

-54.98%

P/VP

-69.30

NVO - Novo Nordisk

$48.77 --25,90% (12 M)

P/L

11.48

3.79%

ROE

60.40%

P/VP

6.93

Frequently Asked Questions

What is the price of Cyclacel Pharmaceuticals (CYCCP) today?

A cotação de Cyclacel Pharmaceuticals (CYCCP) hoje está em US$ 0.00, com uma variação de 0% em relação ao último ano. A cotação de Cyclacel Pharmaceuticals (CYCCP) iniciou o ano negociando na casa dos US$ 0.00 e hoje está em US$ 0.00. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Cyclacel Pharmaceuticals (CYCCP) e dados de ações do Ibovespa e mercados internacionais.

Quando Cyclacel Pharmaceuticals (CYCCP) paga dividendos?

Cyclacel Pharmaceuticals (CYCCP) não distribuiu dividendos no último ano.

Is Cyclacel Pharmaceuticals (CYCCP) a good investment?

Atualmente, Cyclacel Pharmaceuticals (CYCCP) está cotada a US$ 0.00, com um P/L de -8.63, representando um desvio de -863% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 0 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 33.29%. O retorno total do acionista foi de 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Cyclacel Pharmaceuticals (CYCCP) stock?

Investir em ações de Cyclacel Pharmaceuticals (CYCCP) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Cyclacel Pharmaceuticals (CYCCP) yield today?

A rentabilidade de Cyclacel Pharmaceuticals (CYCCP) foi de 0.00% no último mês, 0.00% no último ano e 0.00% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.30 em dividendos, um Dividend Yield de 33.29%.

Se você quisesse comprar 100 ações de Cyclacel Pharmaceuticals (CYCCP) hoje, o investimento total seria de US$ 0.00, com base na cotação atual de US$ 0.00.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 0.00
Em 5 anos: US$ 0.00
Em 10 anos: US$ 0.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

CYCCP

Cyclacel Pharmaceuticals Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment CYCCP

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

current DY: 33.29%

5-year average DY: 794.07%

type

Ex - Dividend Date

payment date

value

ABOUT Cyclacel Pharmaceuticals

Cyclacel Pharmaceuticals Inc.

United States

29 years

2006

12

Financial Results CYCCP

CYCCP cash flow

Asset, Revenue and Profit Growth - CYCCP

CYCCP balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

Frequently Asked Questions